A Phase III, multicenter, randomized, double-blind, active comparator-controlled study to evaluate the safety, tolerability, and immunogenicity of V114 compared with PCV13 in healthy infants (PNEU-PED-EU-1). - Martinon-Torres, Federico; Wysocki, Jacek; Szenborn, Leszek; Carmona-Martinez, Alfonso; Poder, Airi; Dagan, Ron; Richmond, Peter; Gilbert, Christopher; Trudel, Marie-Chantale; Flores, Sheryl; Lupinacci, Robert; McFetridge, Richard; et al. (Vaccine, 2023)